Pioneers in RNA-Based Innovations!!

At exRNA Therapeutics Limited, groundbreaking science and compassion converge to usher in a new era of precision of drug development. Inspired by the intricate functionality of tRNA fragments (tRF), we harness the power of RNA-based therapies to address the unmet needs of patients battling rare diseases, Neurological diseases and autoimmune diseases.

Redefining realm of medicine through ASO Formulations

Antisense oligonucleotides (ASOs) are short, synthetic pieces of nucleic acids designed to specifically bind to the RNA molecules within cells. This binding can alter the expression of genes, offering a targeted approach to treat genetic disorders, including neurological diseases. Our novel ASO formulations, G1 represent a cutting-edge approach in the unmet needs of patients battling rare diseases, Neurological diseases and autoimmune diseases.

Embracing Rare

At exRNA, we understand the complexities of

rare diseases and the unique needs of those affected.

With a focus on DMD and Psoriasis,

we passionately embrace the rare,

cultivating solutions and providing a beacon of hope

for individuals and families navigating these challenging conditions.

Screenshot from_2024_05_26_15_50_33_removebg_preview_5d7cac021b

Non-coding RNA regulation as Future of Therapy

Non-coding RNAs (ncRNAs) regulate gene expression and are key in disease development, influencing cell growth and apoptosis. Dysregulated ncRNAs contribute to conditions like autoimmune disorders and neurological disorders. Targeting ncRNAs offers a promising therapeutic approach by correcting abnormal gene expression, providing precise and effective treatments for diseases lacking targeted therapies

Breakthrough Therapeutic Solutions

Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by challenges in social interaction, communication, and repetitive behaviors. The severity and symptoms of ASD can vary widely among individuals. It typically appears in early childhood and affects the individual's ability to function socially, academically, and in other areas of life.

Duchenne muscular dystrophy (DMD)

Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder causing progressive muscle weakness and degeneration due to mutations in the DMD gene, which leads to a lack of dystrophin protein. It mainly affects boys, with symptoms like delayed walking and difficulty running starting between ages 2 and 5.

Psoriasis

Psoriasis is a chronic autoimmune skin condition causing rapid skin cell growth, leading to red, scaly patches. Commonly affected areas include the scalp, elbows, knees, and lower back. It has genetic, immune, and environmental triggers. Treatments include topical medications, phototherapy, and systemic drugs.